D-0044-2024 Class III Terminated
FDA drug recall D-0044-2024 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Oct 4, 2023 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Feb 2, 2024). Affected quantity: 144 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 25, 2023
- Initiation Date
- Oct 4, 2023
- Termination Date
- Feb 2, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 144 bottles
Product description
Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-737-86
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA.
Code information
Lot #: HAD0360A, Exp. 12/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0044-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026